1. SPARCL TRIAL: HIGH-DOSE ATORVASTATIN AFTER STROKE OR TRANSIENT ISCHEMIC ATTACK PRESENTED BY: TING CHUONG WEI KENNY GOH WEI CHUAN CHEN SIAW MING 12-12-2007 2. Atherosclerosis…

1. HIV Treatment Update Todd Correll, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases/HIV University of North Carolina Hospitals November 2006 2. Objectives…

1. CardiacResynchronisationTherapy September 2008 2. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure (CARE-HF) John G.F. Cleland, M.D.,…

1. CardiacResynchronisationTherapy September 2008 2. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure (CARE-HF) John G.F. Cleland, M.D.,…

1. Primary Care BasedDisease Management VISN 4 MIRECC VA Philadelphia University of Pennsylvania 2. Delivering Quality MH Care in Primary Care Epidemiology Chronic Disease…

1. Impact of an Intensive Lifestyle Change on Coronary Artery Disease. Lissah Dunston Christine Lutz Amanda Werner & Kimberly Werner 2. PICO Summary P- Patients with…

Slide 1Baseline Characteristics According to CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:1948-55 Slide 2 Distribution of Blood Lipid Parameters According to…

Slide 1Prognostic significance of atrial fibrillation/flutter following acute myocardial infarction in patients with diabetes mellitus M.Gashi,E.Pllana,D.Kocinaj,S.Rexhepi…

Slide 1Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-controlled Trials: The Cross Trial Safety Analysis Scott D. Solomon, MD, Janet Wittes, PhD, Ernest Hawk, MD,…

Slide 1TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION IN PAEDIATRIC TYPE 1 DIABETIC PATIENTS WITH PAINFUL NEUROPATHY Sanjay Kalra, Bharti Kalra, Bharti Hospital, Karnal INDIA…